The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR 00653A107   1,092,194 1,377,294 SH   OTR 1,2,3 0 1,377,294 0
ACHILLES THERAPEUTICS PLC SPONSORED ADS 00449L102   9,856,262 11,086,909 SH   OTR 1,2,3 0 11,086,909 0
AUTOLUS THERAPEUTICS PLC SPON ADS 05280R100   137,473,579 21,346,829 SH   OTR 1,2,3 0 21,346,829 0
FREELINE THERAPEUTICS HLDGS SPONSORED ADS 35655L107   9,326,984 1,466,507 SH   OTR 1,2,3 0 1,466,507 0